Industry
Health Care
Topic
IPOs
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
IPOs in Health Care
... DURHAM - Dova Pharmaceuticals, Inc. (NASDAQ: DOVA), a pharmaceutical company focused on acquiring, developing and commercializing drug ...
... firm plans to list on the NYSE as "RCUS." Read more. [ts_bullet_primary] Taiwan Liposome , a Taipei-based biotech developing pain and eye disease drugs, filed ...
... Aimmune Therapeutics, Inc. (NASDAQ:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, ...
... CAMBRIDGE - Ra Pharmaceuticals, Inc. (NASDAQ: RARX) ('Ra Pharma') today announced the pricing of an underwritten public ...
... participated. [ts_bullet_primary] CommonSense Robotics , an Israel-based developer of on-demand technologies using AI and advanced robotics, raised $20 million in Series A funding. Playground Global ...
... TUSTIN, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) today announced that it has commenced an underwritten public ...
... Motus GI Holdings, Inc., ("Motus" or the "Company"), a medical technology company dedicated to improving ...
... REDWOOD CITY, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), ...
... public offering price of $ 164.00 per share. The gross proceeds to Sage Therapeutics from the offering, before deducting the underwriting discounts and commissions and ...
... SEATTLE - CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced the pricing of an underwritten public ...
... Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the ...
... CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced the pricing of an underwritten public ...
... B Capital Group, Ignition Partners, Greycroft and Eight Roads Ventures participated. [ts_bullet_primary] Zenflow Inc , a South San Francisco-based medical device company, raised $31.4 million ...
... NEWTOWN, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX) ("Onconova" or "we"), a Phase 3 stage biopharmaceutical company focused on ...
... Evolus, Inc. ("Evolus"), a medical aesthetics company focused on providing physicians and their patients ...
... MENLO PARK, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ...
... Sage Therapeutics(NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central ...
... Viveve Medical, Inc. ("Viveve") (NASDAQ: VIVE), a medical technology company focused on women's intimate ...
... BOTHELL - Seattle Genetics, Inc. (Nasdaq: SGEN) today announced the pricing of an underwritten public offering ...
... (GlobeNewswire) - Sol-Gel Technologies Ltd. (Sol-Gel) (NASDAQ:SLGL), a clinical-stage dermatology company focused on identifying, developing and ...
... Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that it has commenced an underwritten public offering ...
... inhibitor; AM0003, an anti-LAG-3 checkpoint inhibitor; AM0015, a form of recombinant human Interleukin-15 (IL-15) cytokine; and AM0012, a form of recombinant human Interleukin-12 (IL-12) cytokine. ...
... Nasdaq Global Select Market on January 26, 2018 under the ticker symbol "ARMO." The offering is expected to close on January 30, 2018, subject to ...
... BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of ...
... NEW YORK, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. ("Eyenovia"), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products ...
Subscribe now for full coverage on IPOs in Health Care
Start My Free Trial